Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
This intro covers leveraging an inheritance for debt payoff, including prioritization, tax awareness, and a disciplined payment plan.
22,852 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Savvy savers in their 40s are increasingly splitting 401K contributions between traditional and Roth accounts to bala...
As of May 7, 2026, Trump’s drug-pricing drive shows a mixed outcome: some medicines price cuts, but many others highe...
IonQ posted a 755% YoY jump in Q1 2026 revenue to $64.67 million, but mounting losses and burn risk cast doubt on the...
VTWO outperformed IWM over the past decade, despite both ETFs tracking the same 2,000 small-cap stocks. The wrapper c...
Despite rapid AI adoption, U.S. companies continue outsourcing call-center work to cheaper overseas hubs, with offsho...
Cisco and CrowdStrike rally prompt debate on which name makes the better short bet. The case centers on Cisco's margi...
May delivered a sharp reversal for Bitcoin ETFs, with the biggest weekly outflows since January as risk-off trading s...
A nationwide shift toward local, community-focused shopping is fueling independent book stores growing. New ABA data ...
Energy Select Sector SPDR Fund (XLE) has staged a rebound as crude hits higher levels. Two key signals could set the ...
A bipartisan group of lawmakers asks the FTC to review how online real estate platforms handle referrals, citing disc...
Anthropic’s Claude Code chief reveals three hiring traits—generalist thinking, humility, and data-driven iteration—as...